Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cellular pathways regulate critical cell functions like division, proliferation, survival, and apoptosis.
• Mutations in key genes controlling these pathways can lead to neoplastic transformations and cancer.
• Ovarian cancer, particularly high-grade serous tumors, has a poor prognosis due to late detection and treatment resistance.

Purpose of the Study:

• To review the pathways and key genes involved in ovarian cancer pathology.
• To discuss genetic mutations and aberrant gene functions contributing to ovarian cancer.
• To explore emerging non-genetic mechanisms, including microRNAs (miRNAs) and epigenetics, in ovarian cancer.

Main Methods:

• Review of existing literature on cellular pathways in ovarian cancer.
• Analysis of genetic mutations and aberrant gene functions.
• Inclusion of studies on non-genetic mechanisms like miRNAs and epigenetics.

Main Results:

• Key genes and pathways are frequently mutated or dysregulated in ovarian cancer.
• High-grade serous ovarian tumors exhibit particularly poor outcomes.
• Non-genetic factors, including miRNAs and epigenetic modifications, play a significant role.

Conclusions:

• Understanding molecular pathways and genetic alterations is vital for developing novel ovarian cancer therapeutics.
• Investigating non-genetic mechanisms offers new avenues for prevention and treatment strategies.
• Targeting specific pathways and genes holds promise for improving patient survival rates in ovarian cancer.